*Optimal dilutions/concentrations should be determined by the researcher.
Not tested in other applications.
293T , HeLa , HepG2 , human plasma
0.1M Tris, 0.1M Glycine, 10% Glycerol (pH7). 0.01% Thimerosal was added as a preservative.
Recombinant protein encompassing a sequence within the center region of human C1 inhibitor. The exact sequence is proprietary.
Purified by antigen-affinity chromatography.
For In vitro laboratory use only. Not for any clinical, therapeutic, or diagnostic use in humans or animals. Not for animal or human consumption.
C1IN antibody, C1INH antibody, C1NH antibody, HAE1 antibody, HAE2 antibody, SERPING1 antibody, serpin G1 antibody, serine/cysteine proteinase inhibitor clade G member 1 antibody, C1 esterase inhibitor antibody, complement component 1 inhibitor antibody, plasma protease C1 inhibitor antibody, C1-inhibiting factor antibody, "serpin peptidase inhibitor, clade G (C1 inhibitor), member 1 antibody"
This gene encodes a highly glycosylated plasma protein involved in the regulation of the complement cascade. Its protein inhibits activated C1r and C1s of the first complement component and thus regulates complement activation. Deficiency of this protein is associated with hereditary angioneurotic oedema (HANE). Alternative splicing results in multiple transcript variants encoding the same isoform. [provided by RefSeq]